Glucotrol XL (glipizide) extended release tablets, 5 mg, 100 count bottles, Rx only, Distributed by Roerig, Division of Pfizer Inc, NY, NY --- NDC 0049-1550-66
Published February 12, 2014 · Recall initiated: November 4, 2013
Summary
FDA records drug Class III recall D-1058-2014, published February 12, 2014 and initiated November 4, 2013. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 14,357 bottles; Lot: Lot V120131. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification; 8 hr stability timepoint
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pfizer Inc.
- Distributor
- US nationwide (including PR)
- Lot
- Lot V120131
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only,August 6, 2025
- FDABicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only,August 6, 2025
- FDADOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials,July 2, 2025
- FDALabetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile CartridgeJuly 3, 2024
- FDA50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), 250 mL glass containers, Baxter Healthcare Corp.,February 12, 2014
- FDAGlipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by:February 12, 2014
Questions about this recall
Was Glucotrol XL (glipizide) extended release tablets, 5 mg, 100 count bottles, Rx only, Distributed by Roerig, Division of Pfizer Inc, NY, NY --- NDC 0049-1550-66 recalled?
Yes. FDA published recall D-1058-2014 on February 12, 2014. Reported hazard: Failed Dissolution Specification; 8 hr stability timepoint
What should I do if I have this product?
Voluntary: Firm initiated · Letter